Opinion|Videos|January 22, 2025
Monitoring and Tracking Symptoms of Polycythemia Vera
Author(s)Julie Huynh-Lu, P.A.
A panelist discusses how patients should communicate comprehensively with their care team about symptom patterns, documentation methods, and warning signs of polycythemia vera progression, including key questions to ask themselves about symptom changes and recommended tracking tools.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What should patients tell their physicians about their symptoms?
- What questions do you ask patients when they report their symptoms to you?
- How should patients document their symptoms? Is there a symptom tool you recommend?
- When and why should patients notify their care team about symptom changes? What are some questions that patient should ask themselves about their change in symptoms?
- How can patients recognize and track the early warning signs that their polycythemia vera might be progressing or becoming more active?
Advertisement
Related to this article
Medicare will move ostomy supplies to eight national contracts in 2028. Survivors and clinicians say a poor fit can lead to leaks, infection and hospital stays.
An experimental treatment has kept one patient with heavily pretreated hairy cell leukemia free of detectable disease for more than two years, raising questions about whether CAR T-cell therapy could offer a path toward a cure.
The National Comprehensive Cancer Network released its first patient guideline written for caregivers on Oct. 27, 2026. The free guide covers emotional support, money, legal questions, medical tasks and caregivers' own well-being.
Three phase 3 trials presented at the 2026 ESMO Congress looked closely at swallowing, daily functioning and blood counts in throat, kidney and colorectal cancer. Here is what they found about living well during and after treatment.
New research found that nearly 1 in 5 second-level appeals for denied cancer medications under Medicare Part D were successful, raising questions about how insurers make coverage decisions and what patients can do when their treatment is denied.
Joy Maulik, MSN, FNP-C, explains why a prostate cancer diagnosis should be seen as a change in direction, not an ending, and how patients can lean on education, their providers and caregivers.
Dr. Morana Vojnic answers common questions about brain cancer, including diagnosis, tumor types, treatment effects, recurrence and life after treatment begins.
A national survey study of about 200,000 adults, published in Supportive Care in Cancer, found that people caring for someone with cancer had 89% higher odds of frequent mental distress than people who were not caregivers.
Advertisement
Advertisement
Trending on CURE
1
3 Quality-of-Life Results From ESMO 2026 Patients Should Know
2
4 Long-Term Survival Results From ESMO 2026 Patients Should Know
3
Top 5 Takeaways From ESMO 2026 That Patients Should Know
4
Neuro-Oncologist Answers Common Questions About Brain Cancer Diagnosis and Treatment
5